The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
OCT4: biological functions and clinical applications as a marker of germ cell neoplasia
Abstract
Germ cell tumours (GCTs) are a heterogeneous group of neoplasms, which develop in the gonads as well as in extragonadal sites, that share morphological patterns and an overall good prognosis, owing to their responsiveness to current surgical, chemotherapeutic, and radiotherapeutic measures. GCTs demonstrate extremely interesting biological features because of their close relationships with normal embryonal development as demonstrated by the pluripotentiality of some undifferentiated GCT variants. The similarities between GCTs and normal germ cell development have made it possible to identify possible pathogenetic pathways in neoplastic transformation and progression of GCTs. Genotypic and immunophenotypic profiles of these tumours are also useful in establishing and narrowing the differential diagnosis in cases of suspected GCTs. Recently, OCT4 (also known as OCT3 or POU5F1), a transcription factor that has been recognized as fundamental in the maintenance of pluripotency in embryonic stem cells and primordial germ cells, has been proposed as a useful marker for GCTs that exhibit features of pluripotentiality, specifically seminoma/dysgerminoma/germinoma and embryonal carcinoma. The development of commercially available OCT4‐specific antibodies suitable for immunohistochemistry on paraffin‐embedded specimens has generated increasing numbers of reports of OCT4 expression in a wide variety of gonadal and extragonadal GCTs. OCT4 immunostaining has been shown to be a sensitive and specific marker for seminomatous/(dys)germinomatous tumours and in embryonal carcinoma variants of non‐seminomatous GCTs, whether in primary gonadal or extragonadal sites or in metastatic lesions. Therefore, OCT4 immunohistochemistry is an additional helpful marker both in the differential diagnosis of specific histological subtypes of GCTs and in establishing a germ cell origin for some metastatic tumours of uncertain primary. OCT4 expression has also been reported in pre‐invasive conditions such as intratubular germ cell neoplasia, unclassified (IGCNU) and the germ cell component of gonadoblastoma. Additionally, OCT4 immunostaining shows promise as a useful tool in managing patients known to be at high risk for the development of invasive GCTs. Copyright © 2006 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Niwa, H., Miyazaki, J.-I., & Smith, A. G. (2000) · Nature Genetics · doi:10.1038/74199 · Cited by 3,596
Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, I., Schöler, H., & Smith, A. (1998) · Cell · doi:10.1016/s0092-8674(00)81769-9 · Cited by 3,392
Consensus Statement on Management of Intersex Disorders
Lee, P. A., Houk, C. P., Ahmed, S. F., Hughes, I. A., & in collaboration with the participants in the International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology (2006) · Pediatrics · doi:10.1542/peds.2006-0738 · Cited by 2,324
Consensus statement on management of intersex disorders
Hughes, I. A. (2005) · Archives of Disease in Childhood · doi:10.1136/adc.2006.098319 · Cited by 1,417
Oct‐4 : Gatekeeper in the Beginnings of Mammalian Development
Pesce, M., & Schöler, H. R. (2001) · STEM CELLS · doi:10.1634/stemcells.19-4-271 · Cited by 771
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.
Looijenga, L. H. J., Stoop, H., de Leeuw, H. P. J. C., Brazao, C. A. D. G., Gillis, A., van Roozendaal, K. E. P., van Zoelen, E. J. J., Weber, R. F. A., Wolffenbuttel, K. P., van Dekken, H., et al. (2003) · PubMed · Cited by 639
Self-citationOct4 is required for primordial germ cell survival
Kehler, J., Tolkunova, E., Koschorz, B., Pesce, M., Gentile, L., Boiani, M., Lomelí, H., Nagy, A., McLaughlin, K. J., Schöler, H. R., et al. (2004) · EMBO reports · doi:10.1038/sj.embor.7400279 · Cited by 568
Germ Cell Tumors in the Intersex Gonad: Old Paths, New Directions, Moving Frontiers
Cools, M., Drop, S. L. S., Wolffenbuttel, K. P., Oosterhuis, J. W., & Looijenga, L. H. J. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0005 · Cited by 555
Self-citationOct4 distribution and level in mouse clones: consequences for pluripotency
Boiani, M., Eckardt, S., Schöler, H. R., & McLaughlin, K. J. (2002) · Genes & Development · doi:10.1101/gad.966002 · Cited by 516
Oct-3/4 is a dose-dependent oncogenic fate determinant
Gidekel, S., Pizov, G., Bergman, Y., & Pikarsky, E. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00270-8 · Cited by 441
Cited by
Cheng, L., Albers, P., Berney, D. M., Feldman, D. R., Daugaard, G., Gilligan, T., & Looijenga, L. H. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0029-0 · Cited by 462
Self-citationSaigusa, S., Tanaka, K., Toiyama, Y., Yokoe, T., Okugawa, Y., Ioue, Y., Miki, C., & Kusunoki, M. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0617-z · Cited by 319
Amin, M. B., Epstein, J. I., Ulbright, T. M., Humphrey, P. A., Egevad, L., Montironi, R., Grignon, D., Trpkov, K., Lopez-Beltran, A., Zhou, M., et al. (2014) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000254 · Cited by 314
Self-citationOCT4 Spliced Variants Are Differentially Expressed in Human Pluripotent and Nonpluripotent Cells
Atlasi, Y., Mowla, S. J., Ziaee, S. A. M., Gokhale, P. J., & Andrews, P. W. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0530 · Cited by 289
Metadata
- Authors
- Cheng, L., Sung, M., Cossu‐Rocca, P., Jones, T., MacLennan, G., De Jong, J., Lopez‐Beltran, A., Montironi, R., & Looijenga, L.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2006-11-20
- Volume
- 211
- Issue
- 1
- Pages
- 1-9
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2151210821
- Cited by
- 265
- References
- 29
- FWCI
- 13.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. https://app.cochat.ai/papers/10.1002/path.2105
- The paper
- Cheng, L., Sung, M., Cossu‐Rocca, P., Jones, T., MacLennan, G., De Jong, J., Lopez‐Beltran, A., Montironi, R., & Looijenga, L. (2007). OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. The Journal of Pathology. https://doi.org/10.1002/path.2105
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.